New Trial Frees Type 1 Diabetes Patients from Daily Insulin Jabs
A groundbreaking T1D trial used donor islet cells and Tegoprubart to free patients from daily insulin jabs. Participants stayed insulin-free for up to 14 months.
HealthInnovation
Read More
AI in Healthcare: The New MVP in Every Doctor’s Toolkit
Discover how AI is reshaping healthcare, from sesame seed–sized tumor detection to virtual hospitals. Learn about data challenges, the Chinese mainland’s guidelines, and the future of medicine.
Chinese Mainland Builds World’s Largest Disease Prevention Network
The Chinese mainland has rolled out the world’s largest disease prevention and control system, boosting health literacy and slashing illness rates under its 14th Five-Year Plan.